Advertisement
Advertisement
U.S. Markets open in 9 hrs 1 min
Advertisement
Advertisement
Advertisement
Advertisement

Oncology Pharma Inc. (ONPH)

Other OTC - Other OTC Delayed Price. Currency in USD
0.40000.0000 (0.00%)
At close: 03:55PM EST
Advertisement

Oncology Pharma Inc.

1 Sansome Street
Suite 3500
San Francisco, CA 94104
United States
415-869-1036
https://www.oncology-pharma.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Chuck WagnerPres, Treasurer & ChairmanN/AN/AN/A
Mr. George MalesekInterim Chief Exec. OfficerN/AN/AN/A
Mr. Dimitri Theofilopolous Esq.Legal CounselN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

Corporate Governance

Oncology Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement